Why Malaria Comes Back After Treatment: The Hidden Science Behind Recurrent Malaria and What You Should Do About It

By Stephanie Nwakaegho, Gentechnews Health Columnist

 

For millions of people living in malaria-endemic regions, especially across sub-Saharan Africa, one of the most frustrating experiences is treating malaria successfully only for the symptoms to return weeks later. The fever disappears, the body regains strength, and life seems normal again until the chills, headaches, weakness, and sweating suddenly reappear. Many people interpret this recurrence as proof that malaria “never really leaves the body.” Others blame spiritual causes, weather changes, or weak immunity. In reality, modern medical science shows that recurrent malaria is far more complex.

Malaria can return after treatment for several scientifically recognized reasons. In some cases, the person becomes infected again through another mosquito bite. In other situations, the original parasites survive treatment and multiply again later. Certain malaria species can even remain hidden inside the liver for months before reactivating. Added to this are growing concerns about drug resistance, counterfeit medications, poor treatment adherence, delayed diagnosis, and widespread self-medication.

According to the 2025 World Malaria Report by the World Health Organization (WHO), malaria remains one of the world’s deadliest infectious diseases, causing an estimated 282 million cases and over 610,000 deaths globally in 2024 alone. Around 95% of these deaths occurred in Africa, with children under five carrying the greatest burden.

Despite decades of intervention, recurrent malaria continues to be a major public health challenge in countries like Nigeria, where high mosquito exposure, inadequate sanitation, limited access to quality healthcare, and fake antimalarial drugs worsen the problem.

Understanding why malaria returns is important not only for patients but also for healthcare workers, policymakers, and communities. Recurrent malaria can lead to severe anemia, organ damage, repeated hospital admissions, poor productivity, school absenteeism, and increased risk of death among vulnerable populations.

This column explores the real scientific reasons malaria returns after treatment, the difference between relapse and reinfection, the growing danger of antimalarial drug resistance, and the practical steps individuals and communities can take to reduce recurrence and protect themselves.

Understanding Malaria: What Happens Inside the Body

Malaria is a life-threatening disease caused by parasites of the genus Plasmodium. Humans become infected through the bite of an infected female Anopheles mosquito. Once the mosquito bites a person, parasites enter the bloodstream and travel to the liver, where they mature before invading red blood cells. Inside red blood cells, the parasites multiply rapidly. When the infected blood cells burst, they release more parasites into the bloodstream, triggering symptoms such as fever, chills, sweating, headaches, vomiting, muscle pain, and severe weakness.

The most dangerous species is Plasmodium falciparum, which is responsible for the majority of malaria deaths in Africa. Nigeria, alongside a few other African countries, contributes a disproportionately high percentage of global malaria cases.

The disease is both preventable and curable, yet it remains deeply entrenched in tropical regions due to poverty, environmental conditions favorable to mosquitoes, weak healthcare systems, and growing resistance to drugs and insecticides.

One of the biggest misconceptions about malaria is the belief that every recurring episode means the previous treatment failed. Scientifically, recurrent malaria may occur through three major mechanisms: Reinfection, Recrudescence, and Relapse. These terms are often confused, but they describe very different biological processes.

Reinfection: The Most Common Reason Malaria Returns

In high-transmission regions such as Nigeria, reinfection is the most common explanation for recurrent malaria. Reinfection occurs when a person is treated successfully and clears the original infection, but later receives another infected mosquito bite that introduces new parasites into the body. This means the earlier malaria treatment may have worked perfectly, but the person simply became infected again.

In many African communities, people are constantly exposed to mosquitoes due to:

• Poor drainage systems
• Stagnant water
• Lack of insecticide-treated nets
• Hot climates favorable to mosquito breeding
• Inadequate housing protection
• Limited mosquito control programs

Because mosquitoes are abundant in endemic regions, a person can recover from malaria and become infected again within days or weeks. The WHO notes that distinguishing reinfection from treatment failure is particularly difficult in high-transmission African settings. This explains why some individuals report having malaria every month. In many cases, these are not old parasites reawakening but entirely new infections caused by repeated mosquito exposure. Children are especially vulnerable because their immunity is not fully developed. Pregnant women are also at increased risk due to immune changes during pregnancy.

Recrudescence

Another major cause of recurrent malaria is recrudescence. Recrudescence occurs when antimalarial treatment reduces parasite levels temporarily but fails to eliminate all parasites completely. The remaining parasites survive quietly in the bloodstream and begin multiplying again after days or weeks. This situation is often mistaken for reinfection, but scientifically it is different because the returning parasites are from the original infection.

Several factors contribute to recrudescence:

• Incomplete Treatment:Many patients stop taking medication once symptoms improve. Fever often disappears before all parasites are eliminated, leading people to believe they are fully cured. When treatment is stopped early, surviving parasites continue reproducing and eventually trigger another malaria episode.
• Fake or Substandard Drugs:Counterfeit antimalarial drugs remain a serious problem across many low- and middle-income countries. Some medicines contain insufficient active ingredients, while others are poorly stored or expired. Substandard drugs may temporarily suppress symptoms without fully killing the parasites, increasing the likelihood of recurrence.
• Drug Resistance:Drug resistance is becoming one of the greatest threats to global malaria control. Over time, malaria parasites evolve genetic mutations that help them survive medications. Partial resistance to artemisinin-based therapies, which are currently the cornerstone of malaria treatment worldwide, has now been confirmed or suspected in multiple African countries. Scientists fear that widespread resistance could reverse decades of progress. Research published in 2025 examining recrudescence after artemether-lumefantrine treatment demonstrated that malaria parasites can persist despite standard therapy under certain conditions.
• Vomiting or Poor Drug Absorption:Patients who vomit shortly after taking medication may not absorb enough drug into the bloodstream. Similarly, malnutrition, gastrointestinal disorders, or incorrect dosing can reduce drug effectiveness.

Relapse

Relapse is different from both reinfection and recrudescence. Certain malaria species, particularly Plasmodium vivax and Plasmodium ovale, can form dormant stages known as hypnozoites inside the liver. These hidden parasites may remain inactive for weeks, months, or even years before reactivating and causing another malaria episode.

Although Plasmodium falciparum dominates in Nigeria and most of West Africa, relapse remains an important scientific phenomenon globally. This hidden liver stage is one reason malaria elimination remains difficult in many regions of Asia and Latin America.

The Growing Crisis of Antimalarial Drug Resistance

Drug resistance represents one of the most alarming developments in global malaria control. Historically, drugs such as chloroquine were highly effective. However, widespread misuse allowed resistant parasites to emerge. Today, scientists are witnessing a similar threat involving artemisinin-based combination therapies (ACTs). WHO’s latest reports emphasize that resistance is spreading and threatens decades of progress. Experts fear that if resistance continues increasing, malaria deaths could rise dramatically, particularly in Africa where the burden is already highest.

Drug resistance develops faster when patients fail to complete treatment, counterfeit drugs circulate, or medications are used unnecessarily. This creates evolutionary pressure that favors the survival of resistant parasites.

Why Some People Keep Getting Malaria Again and Again

For many people living in malaria-endemic countries, malaria does not feel like a disease that ever truly ends. One week the medication works, and the next, the chills return. The truth is that some people are far more exposed than others. A person living in an environment filled with stagnant water and blocked drainage may recover today and be bitten again tomorrow. In many African communities, mosquito exposure is not occasional; it is constant.

The problem becomes worse when combined with poverty. Many families still sleep without insecticide-treated mosquito nets or live in homes without window screens. In these conditions, nighttime mosquito bites become almost unavoidable. Children and pregnant women face the highest risks due to their unique immune profiles, making repeated illness more common and dangerous.

The Dangerous Culture of Self-Medication

One of the biggest contributors to recurrent malaria is self-medication. For decades, malaria has become so common that many people automatically assume every fever is malaria. They buy drugs from nearby chemists or roadside vendors without proper testing. At first glance, this seems practical especially as hospitals are either too expensive or far away. But not every fever is malaria. Diseases such as typhoid fever, urinary tract infections, and pneumonia produce similar symptoms. When patients treat themselves without testing, the real illness worsens.

Even more dangerous is the circulation of fake drugs. Across several African countries, counterfeit medications have become a major crisis. Symptoms may improve temporarily, while some parasites survive quietly, leading to recrudescence weeks later. This creates the frightening impression that treatment never works.

Nurse’s Insight

Malaria should never be treated casually. Every suspected case deserves proper testing. Every prescribed medication should be completed fully. And every individual, family, and community must recognize that malaria prevention is just as important as malaria treatment. Sleeping under insecticide-treated nets, eliminating stagnant water, improving environmental sanitation, seeking laboratory-confirmed diagnosis, and avoiding self-medication are life-saving actions.

The fight against malaria is no longer only about curing infection after it happens. It is about breaking the cycle that allows the disease to keep returning in the first place. Until healthcare systems become more effective and public awareness improves, recurrent malaria will continue to affect millions. However, through education and united public health efforts, this cycle can be broken.

 

Stephanie Nwakaegho, Gentechnews Health Columnist can be reached via thestephanienwakaegho@gmail.com